Case Report: ALK rearranged locally advanced lung adenocarcinoma showing inconsistent radiographic findings and pathological responses during neoadjuvant alectinib therapy

• Main Authors: Peijun Cao (Author), Qingchun Zhao (Author), Yongwen Li (Author), Ruifeng Shi (Author), Guangsheng Zhu (Author), Zihe Zhang (Author), Hongbing Zhang (Author), Minghui Liu (Author), Sen Wei (Author), Hongyu Liu (Author), Jun Chen (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Alectinib has been approved as first-line treatment for anaplastic lymphoma kinase (ALK)-positive non-small cell lung carcinoma. Oncologists are also exploring the possibility of applying alectinib in the perioperative period. Here, we present a patient with locally advanced lung adenocarcinoma asso...